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EpigeneticsEpigenetics as coined by the British biologist Conrad Wadding-
ton to explain differentiation [1] deals with alterations in gene
expression unrelated to changes in DNA sequences. Although not
based on DNA mutations, epigenetic changes are clonally inherit-
able from one cell to the other, potentially modiﬁed by environ-
mental stimuli and even transmitted from parent to offspring in
some instances. Epigenetic processes play an important role in
the earliest stages of development when epigenetic modiﬁcations
of chromatin structure, such as DNA methylation, cause lifelong
and sometimes trans-generational traits [2]. Besides DNA methyla-
tion, speciﬁc epigenetic mechanisms among others comprise
histone modiﬁcations (e.g. by Polycomb–Trithorax protein com-
plexes), ATP-dependent chromatin remodeling and non-coding
RNA-mediated gene-silencing. Most of these epigenetic processes
have an impact on chromatin organization and maintenance, and
occur inmany species affecting important biological processes such
as genomic imprinting, X-inactivation, reprogramming in embryo-
genesis, and chromosomal structures. The past few years have seen
an explosion of knowledge in the molecular mechanisms of epige-
netics, along with the realization that epigenetic processes could
also result in phenotypic variation [3]. Given that diseases are phe-
notypes, it is not surprising that impaired epigenetic processes are a
major fundamental risk in acquired disorders such as cancer and
thus epigenetic drug-based chemotherapeutic approaches are sub-
jects of intense research [4].
The present Special Issue on EPIGENETICS comprises 16 reviews
covering the topics of DNA methylation [5–7], histone modiﬁcation
and chromatin regulation [8,9], environmental epigenetics [10–12],
developmental plasticity [13,14], cancer epigenetics [15–18] and epi-
genetics and therapeutic potential [19,20]. The editors thank the
authors and reviewers for their efforts and hope that the readers
will enjoy this updated, comprehensive and foresighted discussion
on ongoing epigenetic research.
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